M. Alakloby, Omar
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
12.10.2017
New patient group „men“ – hyaluronic acid as an important tool
In our dermatology practice we use increasingly cross-linked fillers in men, such as Z FILL Deep2 for regenerative augmentation. On behalf of a 47 year old man, the approach and […]
01.11.2016
Australian Medical Board issues guidelines on cosmetic medical and surgical procedures
The Medical Board of Australia has issued guidelines for medical practitioners who perform cosmetic medical and surgical procedures. ‘The guidelines will help keep patients safe, without imposing an […]